Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMNP

Immune Pharmaceuticals (IMNP) Stock Price, News & Analysis

Immune Pharmaceuticals logo

About Immune Pharmaceuticals Stock (NASDAQ:IMNP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
12.29 million shs
Market Capitalization
$8.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMNP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMNP Stock News Headlines

Best Immunity Supplements for 2024
Americans are rushing into gold (but not billionaires!)
Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.
See More Headlines

IMNP Stock Analysis - Frequently Asked Questions

Immune Pharmaceuticals Inc (NASDAQ:IMNP) issued its quarterly earnings data on Tuesday, May, 15th. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.05.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immune Pharmaceuticals investors own include Neovasc (NVCN), LadRx (CYTR), Biopharmx (BPMX), Synergy Pharmaceuticals (SGYP), Gevo (GEVO), Sorrento Therapeutics (SRNE) and Novavax (NVAX).

Company Calendar

Last Earnings
5/15/2018
Today
8/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMNP
Previous Symbol
OTCMKTS:EPCT
CIK
1208261
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
49,313,000
Free Float
N/A
Market Cap
$8.14 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:IMNP) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners